Evidence map›Paper›PMID 33850267›Full record

ArticleScientific reports2021

The efficacy of CRISPR-mediated cytosine base editing with the RPS5a promoter in Arabidopsis thaliana.

Minkyung Choi, Jae-Young Yun, Jun-Hyuk Kim, Jin-Soo Kim, Sang-Tae Kim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Genome editing.Scientific reports · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. The Functional Association ofInternational journal of molecular sciences · 2021
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Minkyung Choi *Center for Genome Engineering, Institute for Basic Science, Daejeon, 34126, Republic of Korea.
Jae-Young Yun *Center for Genome Engineering, Institute for Basic Science, Daejeon, 34126, Republic of Korea.ORCID 0000-0003-4303-6751
Jun-Hyuk KimDepartment of Medical and Biological Sciences, The Catholic University of Korea, Bucheon, 14662, Republic of Korea.
Jin-Soo KimCenter for Genome Engineering, Institute for Basic Science, Daejeon, 34126, Republic of Korea. jskim01@snu.ac.kr.ORCID 0000-0003-4847-1306
Sang-Tae KimCenter for Genome Engineering, Institute for Basic Science, Daejeon, 34126, Republic of Korea. stkim@catholic.ac.kr.ORCID 0000-0003-1645-6021
Institute for Basic Science · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR/Cas9-mediated genome editing is an important and versatile technology in modern biological research. Recent advancements include base-editing CRISPR tools that enable targeted nucleotide substitutions using a fusion protein comprising a nickase variant of Cas9 and a base deaminase. Improvements in base editing efficiencies and inheritable of edited loci need to be made to make CRISPR a viable system in plants. Here, we report efficiency of cytosine base editors (CBEs) in Arabidopsis thaliana by applying the strong endogenous RPS5a promoter to drive the expression of nickase Cas9 and either rAPOBEC1 from rat (BE3) or the PmCDA1 activation-induced cytidine deaminase from sea lamprey (AIDv2). Compared with the strong heterologous CaMV35S promoter of viral origin, the RPS5a promoter improved CBE efficiency by 32% points with the number of T

Indexed as

ArabidopsisCRISPR-Cas SystemsCytosineGene EditingPromoter Regions, GeneticAnimalsArabidopsis ProteinsPlants, Genetically ModifiedRatsRibosomal ProteinsArabidopsis ProteinsCytosineRibosomal Proteins

Identifiers

PMID33850267
PMCPMC8044221
OpenAlexW3153471580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.